Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Level ll Quote
View:
Post by knoxt on Jan 11, 2022 2:33pm

Level ll Quote

THERALASE TECHNOLOGIES INC (CA: TLT)


          
Real-time  

Last: 0.350   Change: 0.015    Volume: 209,584   Last Trade: 14:31  

  Level ll Quote
  Bid   Ask
  Price   Total Size   # of Orders   Price   Total Size   # of Orders
$0.345 24500 3 $0.355 44500 2
$0.34 5500 1 $0.36 62500 3
$0.335 25500 3 $0.37 51000 3
$0.33 11000 2 $0.375 15000 1
$0.325 7500 1 $0.38 36500 8
$0.32 10000 2 $0.395 35000 2
$0.315 3500 2 $0.40 74500 5
$0.31 14000 3 $0.415 500 1
$0.305 8000 1 $0.42 35500 3
$0.30 36500 2 $0.425 7000 1
 
Comment by Oden6570 on Jan 11, 2022 2:36pm
Now .36 on the ask ! Go TLT Go ! 
Comment by Oden6570 on Jan 11, 2022 2:39pm
Now .37 on the ask :-)
Comment by Oden6570 on Jan 11, 2022 2:43pm
.37 being bought ! Hmmm just perhaps we have a NR soon !
Comment by GRAMPS1996 on Jan 11, 2022 2:48pm
If i had the funds to push  this stock up it  would be over $2.00 bucks right now :) 
Comment by Lesalpes29 on Jan 11, 2022 2:51pm
Almost nothing traded on ATS. No manipulation today ... it seems. GL
Comment by Mikee3003 on Jan 11, 2022 2:53pm
Looks like someone parked a tank at .37 and .38.....let's see if we get the volume to break through! C'mon .50!
Comment by robertshaw on Jan 11, 2022 3:01pm
that's blowjobjoe's bosses' last resitsance, after we surpass 0.38, all the way to 0.78.
Comment by menoalittle on Jan 11, 2022 3:17pm
>> Looks like someone parked a tank at .37 and .38.... eh. just throw a few javelin missiles at 'em. (or call in a couple Warthogs...)
Comment by CAinPlap on Jan 11, 2022 3:33pm
If I had the funds, i would have taken this private.  :)
Comment by Oilminerdeluxe on Jan 11, 2022 2:41pm
It appears my 100 bucks sparked the fuse..
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250